Schizophrenia Bulletin

Schizophrenia Bulletin (commonly abbreviated as Schizophr. Bull.) is a peer-reviewed journal published by Oxford University Press on behalf of the Maryland Psychiatric Research Center, issued bimonthly. Founded in 1969, it publishes research on the aetiology, pathophysiology and treatment of schizophrenia and related disorders.《精神分裂症公报》（Schizophrenia Bulletin，常用缩写为 Schizophr. Bull.）是一份由牛津大学出版社代表马里兰精神病学研究中心出版的同行评审学术期刊，双月刊。该刊创刊于 1969 年，刊载精神分裂症及相关障碍的病因、病理生理与治疗研究。

Scope

The journal's editorial stance covers the full range from molecular basis to social and cultural factors, accepting both mechanistic research at the molecular level and studies of social factors at the population level, and it plainly emphasises translational reports that simultaneously highlight basic neurobiological mechanisms and clinical manifestations. It sets part of its content as invited special features, with the remaining pages devoted to high-quality unsolicited manuscripts. Its principal subject areas include:本刊的取稿立场是「以从分子基础到社会文化的全谱为覆盖范围」，即同时接受分子层面的机制研究与人群层面的社会因素研究，并明确强调同时突出基础神经生物学机制与临床表现的转化报告。刊物同时把部分内容设为特邀专题，其余篇幅用于高质量自投稿件。收文覆盖的主要方向包括：

• Aetiology and pathogenesis: genetic and environmental factors, neurodevelopment, and aetiological research on schizophrenia.病因与发病机制： 遗传与环境因素、神经发育与精神分裂症的病因学研究。
• Cognition and clinical symptoms: cognitive impairment, positive and negative symptoms, and methods of their assessment.认知与临床症状： 认知损害、阳性与阴性症状及其评估方法。
• Treatment and intervention: pharmacological treatment, psychosocial intervention, and predictors of treatment response.治疗与干预： 药物治疗、社会心理干预与治疗反应的预测因素。
• Prodrome and high risk: screening for prodromal symptoms, identification of high-risk populations, and early intervention.前驱期与高风险： 前驱症状筛查、高风险人群识别与早期干预。
• Biomarkers and resources: fluid biomarkers on the schizophrenia spectrum and the building of biorepositories.生物标志物与资源： 精神分裂症谱系的体液生物标志物与生物样本库建设。

The journal is a hybrid title. The subscription route charges authors nothing, while open access article processing charges can be met through institutional read and publish agreements. The publisher publishes neither an acceptance rate nor a review duration for this title, and the library's previous notes of relatively hard acceptance and a relatively slow four to eight weeks had no official basis and have been deleted. The journal is indexed in the Science Citation Index Expanded and carries a 2025 impact factor of 5.7 and a CiteScore of 10.9.该刊属混合出版模式：订阅路线不向作者收费，选择开放获取可经机构「阅读与发表」协议支付文章处理费。出版方不公布该刊录用比例与审稿时长，库内原记录用率「相对较难」与审稿「相对较慢，4 至 8 周」均无官方依据，已删除。该刊被科学引文索引扩展版收录，2025 年影响因子 5.7、引用分数 10.9。

History

• Founding (1969): the journal was founded in 1969 as a title of the Maryland Psychiatric Research Center from the outset, and the library's record of the founding year agrees with the official statement.创刊（1969年）： 本刊创刊于 1969 年，自创刊起即为马里兰精神病学研究中心的刊物；库内所记创刊年与官方一致。^[1]
• Current editor: James M. Gold serves as editor-in-chief, based at the Maryland Psychiatric Research Center, his editorship recorded in the editors' block of the publisher's official journal page. The library's record of the editor agrees.现任主编： 詹姆斯·戈德（James M. Gold）任主编，供职于马里兰精神病学研究中心；其主编身份在出版方官方期刊页的编者栏中载明。库内所记主编与其一致。^[1]
• Former editor: William T. Carpenter served as the previous editor-in-chief, based at the University of Maryland School of Medicine, and the board structure formed during his tenure has been carried on by the current editor.前任主编： 威廉·卡彭特（William T. Carpenter）任前任主编，供职于马里兰大学医学院；其任内形成的编委会架构由现任主编延续。^[1]
• Sister journal: the journal has an online-only, fully open access sister title, Schizophrenia Bulletin Open, published from 2020, the two forming a parallel arrangement of open access and subscription.姊妹刊物： 该刊另设纯在线、完全开放获取的姊妹刊《精神分裂症公报开放版》，2020 年起出版；姊妹刊与本刊形成开放获取与订阅并行的格局。^[1]
• Supplements and features: the journal publishes supplements at intervals, among which the hallucinations research conference and abstracts of the Schizophrenia International Research Society annual meeting form an important source of its feature content.增刊与专题： 该刊定期出版增刊，其中幻觉研究会议、国际精神分裂症研究会年会摘要等构成其专题内容的重要来源。^[1]
• Metric trend: the 2025 impact factor of 5.7, together with a CiteScore of 10.9, places the journal in the medical class 1 zone of the Chinese Academy of Sciences ranking, with the psychiatry sub-category at zone 1 and a five-year impact factor of 6.0.指标走势： 影响因子自 2025 年的 5.7 与引用分数 10.9 共同刻画该刊位置；中科院分区中列于医学大类一区、精神病学小类一区，五年影响因子 6.0。^[1]

Editors

The journal operates under a single editor-in-chief appointed jointly by Oxford University Press and the Maryland Psychiatric Research Center, with a managing editor and a number of associate editors in support, and manuscripts submitted through the publisher's own submission system. The publisher publishes no editorial process detail beyond the journal's positioning.本刊实行主编负责制，主编由牛津大学出版社与马里兰精神病学研究中心共同任命并主持编辑部，另设管理编辑与若干副编辑；稿件经出版方自有的投稿系统投递。官方不公布除期刊定位之外的编辑流程细节。

• James M. Gold (current editor-in-chief): a researcher at the Maryland Psychiatric Research Center and the University of Maryland School of Medicine, working on cognitive impairment and neural mechanisms in schizophrenia, his editorship recorded in the editors' block of the publisher's official journal page.詹姆斯·戈德（现任主编）： 马里兰精神病学研究中心与马里兰大学医学院研究者，研究方向为精神分裂症的认知损害与神经机制；其主编身份在出版方官方期刊页的编者栏中载明。^[1]
• William T. Carpenter (former editor-in-chief): professor at the University of Maryland School of Medicine, who long headed the journal's editorial office. During his tenure the journal completed the transition from print to digital and built up its supplement system.威廉·卡彭特（前任主编）： 马里兰大学医学院教授，长期主持该刊编辑部；其任内该刊完成了从印刷到数字化的转型并增设增刊体系。^[1]
• Associate editors: the journal's associate editors come from Ireland, Germany, Norway, the United States, Australia, the United Kingdom and the Netherlands, forming its international review capacity.副编辑构成： 该刊副编辑来自爱尔兰、德国、挪威、美国、澳大利亚、英国与荷兰等国，构成其国际化的评审力量。^[1]
• Acceptance and speed: the publisher publishes neither an acceptance rate nor a review duration for this title. The library's previous notes of relatively hard acceptance and a relatively slow four to eight weeks had no official basis and have been deleted.录用与时效： 出版方不公布该刊录用率与审稿时长；库内原记录用率「相对较难」与审稿「相对较慢，4 至 8 周」均无官方依据，已删除。^[1]
• Standing in the field: the journal is regarded as one of the principal titles in psychiatry, its translational research cited directly in schizophrenia guidelines, and together with the other psychiatry titles in the field it forms the publication base of psychiatry.学科地位： 该刊被视为精神病学领域的主要刊物之一，其转化研究常被精神分裂症指南直接引用，与该领域的其他精神病学刊物共同构成精神病学的发表底座。^[1]